Uwe Peukert
Technik-/Wissenschafts-/F&E-Leiter bei NewVac LLC
Profil
Dr. Uwe Peukert is SVP-Strategic Investment Initiative at Torrey Pines Investment, Inc. He has over 25 years hands-on experience in the medical field of which he was practicing medicine and medical science for 14 years and he is in his 12th year working within the field of biotechnology and pharmaceutical industry.
Uwe has joined the management team of Torrey Pines Investment, Inc. as a€?SVP Strategic Investment Initiativesa€? and he continues to be the CEO and President of PharmaSearchEval LLC.
He is a highly experienced medical doctor (Board eligible in US for Pediatrics, Neonatology/Intensive Care and Pediatric Cardiology, Board certified in Germany), with a deep scientific foundation (PhD in Pharmacology/Toxicology of Medical School Hannover, Germany).
During the past decade he established a highly successful record of accomplishment in several business development roles serving large and mid-size pharmaceutical companies.
Previously, Dr. Peukert was Senior Director at Onyx Pharmaceuticals where he was responsible for the search and evaluation function within the business development department.
He initiated and lead the technical evaluation/DD resulting in the acquisition of Proteolix Inc (2009, South San Francisco) and the out-licensing of Japanese rights to Carfilzomib to Ono Pharmaceuticals (2010, Osaka/Japan).
Aktive Positionen von Uwe Peukert
Unternehmen | Position | Beginn |
---|---|---|
NewVac LLC
NewVac LLC Medical/Nursing ServicesHealth Services NewVac LLC is a holding company, which engages in the development of cancer therapy methods. The firm focuses in the investigation of the effectiveness and development of therapeutic vaccines and new indications registered as immunotherapeutic methods in oncology. It also specializes in personalized medicine, combination of cancer therapy, and GMP production of vaccines and cellular products. The company was founded in 2010 and is headquartered in Khimki, Russia. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Uwe Peukert
Unternehmen | Position | Ende |
---|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California. | Private Equity Investor | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California. | Finance |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
NewVac LLC
NewVac LLC Medical/Nursing ServicesHealth Services NewVac LLC is a holding company, which engages in the development of cancer therapy methods. The firm focuses in the investigation of the effectiveness and development of therapeutic vaccines and new indications registered as immunotherapeutic methods in oncology. It also specializes in personalized medicine, combination of cancer therapy, and GMP production of vaccines and cellular products. The company was founded in 2010 and is headquartered in Khimki, Russia. | Health Services |